Results 101 to 110 of about 59,798 (297)

The efficacy of the modified Atkins diet in North Sea Progressive Myoclonus Epilepsy: an observational prospective open-label study

open access: yesOrphanet Journal of Rare Diseases, 2017
BackgroundNorth Sea Progressive Myoclonus Epilepsy is a rare and severe disorder caused by mutations in the GOSR2 gene. It is clinically characterized by progressive myoclonus, seizures, early-onset ataxia and areflexia. As in other progressive myoclonus
M. V. van Egmond   +10 more
semanticscholar   +1 more source

Hepatic disease as the first manifestation of progressive myoclonus epilepsy of Lafora [PDF]

open access: yes, 2007
5 páginas, 2 figuras -- PAGS nros. 1369-1373Background: Lafora disease (LD; progressive myoclonus epilepsy type 2; EPM2) is an autosomal recessive disorder caused by mutations in the EPM2A and EPM2B genes.
Berciano, Javier   +9 more
core   +2 more sources

A two‐sample Mendelian randomization study and mediation analysis exploring the link between cathepsins and epilepsy

open access: yesEpilepsia Open, EarlyView.
Abstract Objective This study aims to investigate the causal relationship between cathepsins and epilepsy, using Mendelian randomization (MR) and mediation analysis. Methods Publicly accessible summary statistics on epilepsy were obtained from FinnGen and the International League Against Epilepsy Consortium.
Huaiyu Sun   +7 more
wiley   +1 more source

Effect of butorphanol on etomidate-induced myoclonus: a systematic review and meta-analysis

open access: yesDrug Design, Development and Therapy, 2019
Jun Hua,1 Shuai Miao,2 Mengzhu Shi,2 Qing Tu,3 Xiuli Wang,2 Su Liu,2 Guanglei Wang,2 Jianhui Gan31Department of Anesthesiology, The 101 Hospital of Chinese People’s Libration Army, Wuxi, Jiangsu, People’s Republic of China; 2Department of ...
Hua J   +7 more
doaj  

Negative myoclonus as a manifestation of cefepime neurotoxicity

open access: yesClinical Case Reports
Key Clinical Message Negative myoclonus may present in the early stages of cefepime neurotoxicity. Cefepime neurotoxicity typically presents as reduced consciousness, myoclonus, and seizures; however, negative myoclonus is uncommon.
Daichi Umemoto   +2 more
doaj   +1 more source

Response of spinal myoclonus to a combination therapy of autogenic training and biofeedback

open access: yesBioPsychoSocial Medicine, 2007
Introduction Clinical evidence indicates that certain types of movement disorders are due to psychosomatic factors. Patients with myoclonic movements are usually treated by a variety of therapeutic agents.
Kempuraj Duraisamy   +3 more
doaj   +1 more source

Diagnosis and Management of Opsoclonus-Myoclonus-Ataxia Syndrome in Children [PDF]

open access: gold, 2022
Thomas Rossor   +16 more
openalex   +1 more source

Signs and symptoms preceding the diagnosis of Alzheimer’s disease: a systematic scoping review of literature from 1937 to 2016 [PDF]

open access: yes, 2017
Objective Late diagnosis of Alzheimer’s disease (AD) may be due to diagnostic uncertainties. We aimed to determine the sequence and timing of the appearance of established early signs and symptoms in people who are subsequently diagnosed with AD ...
Bature, Fidelia   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy